MetaCap

Caribou Biosciences (CRBU) vs Genenta Science S.p.A. (SAEN)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Caribou Biosciences is the larger company by market cap ($30.7 million vs $24.5 million), about 1.3 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CRBU-38.11%SAEN-47.19%
+2%-24%-50%
Nov 3, 20261 yearNov 20, 2026
CRBU-36.64%SAEN-23.70%
+2%-18%-38%
Nov 2, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CRBU versus SAEN key metrics
MetricCRBUSAEN
Share price$0.2843$0.5074
Market cap$30.71M$24.47M
1-day change-8.44%-9.39%
YTD return-82.12%—
1-year return-83.75%—
5-year return-98.39%—
EPS (TTM)$-1.03$-0.37
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$11.16M—
Revenue growth (YoY)+11.66%—
Net income (latest FY)$-148.13M—
Operating margin-1329.37%—
Net margin-1327.40%—
52-week high$2.49$2.58
52-week low$0.2819$0.50
Distance from 52-week high-88.58%-80.33%
Analyst consensusbuy—
Avg. price target upside+1922.51%—
Average volume2.87M85.01K
Shares outstanding108.04M48.22M
Employees979
SectorHealth CareHealth Care
IndustryBiotechnology: Biological Products (No Diagnostic Substances)Biotechnology: Biological Products (No Diagnostic Substances)

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Caribou Biosciences

CRBU stock →

Caribou Biosciences, Inc. operates as a clinical-stage clustered regularly interspaced short palindromic repeats (CRISPR) genome-editing biopharmaceutical company.

Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 97 employees

About Genenta Science S.p.A.

SAEN stock →

Genenta Science S.p.A. operates as a strategic consolidator that focuses on acquiring ownership of privately held companies operating in Italian national-security-regulated sectors.

Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 9 employees

CRBU vs SAEN FAQ

Which is bigger, Caribou Biosciences or Genenta Science S.p.A.?

Caribou Biosciences (CRBU) is larger, with a market capitalization of $30.71M compared with $24.47M for Genenta Science S.p.A. (SAEN).

Are Caribou Biosciences and Genenta Science S.p.A. in the same industry?

Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.

More comparisons